TrianglePUBLICATIONS · 19720909
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Oct 1
- First author
- Monk BJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Monk BJ
- type
- Author
- name
- Sill MW
- type
- Author
- name
- McMeekin DS
- type
- Author
- name
- Cohn DE
- type
- Author
- name
- Ramondetta LM
- type
- Author
- name
- Boardman CH
- type
- Author
- name
- Benda J
- type
- Author
- name
- Cella D
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Monk BJ
- type
- Author
- name
- Sill MW
- type
- Author
- name
- McMeekin DS
- type
- Author
- name
- Cohn DE
- type
- Author
- name
- Ramondetta LM
- type
- Author
- name
- Boardman CH
- type
- Author
- name
- Benda J
- type
- Author
- name
- Cella D
- type
- Author
- bibliography ids
- nci-bib-057648883e859010740ee522
- book metadata
- content sha256
- 2367d426f5556df4cffc2ee4478da26d2d010f89b48701c360e9fe9291958e27
- document type
- citation
- dois
- 10.1200/JCO.2009.21.8909
- electronic publication date
- display
- 2009 Aug 31
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19720909
- immutable id
- pubmed:19720909@2367d426f5556df4cffc2ee4478da26d2d010f89b48701c360e9fe9291958e27
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 28
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4649-55
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19720909
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- 6781002ba65f3473bb6b832485a6d27f8db49748b3883bda08b7fcc066215705
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2009 Oct 1
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.
Preserved source evidence · Not medical advice